Netrin G1 Ligand is a new stromal immunomodulator that promotes pancreatic cancer
D. Barbosa Vendramini-Costa, R. Francescone, J. Franco-Barraza, T. Luong, M. Graves, A. Musa de Aquino, N. G. Steele, J. C. Gardiner, S. A. Alcantara dos Santos, C. Ogier, E. Malloy, L. Borghaei, E. Martinez, D. I. Zhigarev, Y. Tan, , E. Cukierman
This paper identifies NGL-1 as a stromal immunomodulator in pancreatic cancer that promotes tumor growth by modulating the tumor microenvironment through TGF-β and transcription factor pathways.
bioRxiv · May 15, 2024 · PreprintCancer Biology